PCV chemotherapy for recurrent glioblastoma

Neurology

Volumn 66, Issue 4, 2006, Pages 587-589

  Schmidt, F ^a   Fischer, J ^a   Herrlinger, U ^a   Dietz, K ^b   Dichgans, J ^a   Weller, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; STEROID; TEMOZOLOMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; PCV PROTOCOL;

ADULT; AGED; ALLERGY; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; FATIGUE; FEMALE; GLIOBLASTOMA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; BRAIN TUMOR; CLINICAL TRIAL; DISEASE COURSE; DISEASE FREE SURVIVAL; MIDDLE AGED; RECURRENT DISEASE; TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; PROCARBAZINE; RECURRENCE; TIME FACTORS; VINCRISTINE;

EID: 32944481699     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000197792.73656.c2     Document Type: Article

References (10)

1. Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-1018.
2. Wong ET, Hess KR, Gleason MJ, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 1999;17:2572-2578.
3. Yung WKA, Albright RE, Olson J, et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000;83:588-593.
4. Neuro-Oncology Working Group (NOA) of the German Cancer Society. Neuro-Oncology Working Group (NOA)-01 trial of ACNU/VM26 versus ACNU/Ara-C chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 2003;21:3276-3284.
5. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996.
6. Weller M, Streffer J, Wick W, et al. Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma: a phase II study. Cancer 2001;91:423-427.
7. Wick W, Hermisson M, Küker WM, et al. Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma. A phase II study. J Neurooncol 2002;59:151-155.
8. De Wit MC, de Bruin HG, Eijkenboom W, et al. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 2004;63:535-537.
9. Rappelle AC, Postma TJ, Taphoorn MJB, et al. PCV chemotherapy for recurrent glioblastoma multiforme. Neurology 2001;56:118-120.
10. Brandes AA, Tosoni A, Amista P, et al. How effective is BCNU in recurrent glioblastoma in the modern area? Neurology 2004;63:1281-1284.